Status:
UNKNOWN
Optimizing Cervical Cancer Screening Modalities
Lead Sponsor:
Addis Ababa University
Collaborating Sponsors:
Martin-Luther-Universität Halle-Wittenberg
Charite University, Berlin, Germany
Conditions:
Cervical Cancer
Eligibility:
FEMALE
30-49 years
Phase:
NA
Brief Summary
This project aims to optimize cervical cancer screening adherence comparing Arm A (VIA) and Arm B self-sampled Human Papilloma Virus (HPV) testing and determine the molecular epidemiology of HPV, pers...
Detailed Description
Cervical cancer is the second most common cancer in women worldwide but the commonest in developing countries. In Ethiopia, cervical cancer is the leading cause of morbidity and mortality from all can...
Eligibility Criteria
Inclusion
- Women aged between 30 and 49
Exclusion
- women with History of hysterectomy or cervical cancer, pregnant women, not meet the eligibility criteria and unable to give consent.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2019
Estimated Enrollment :
1760 Patients enrolled
Trial Details
Trial ID
NCT03281135
Start Date
January 1 2018
End Date
May 1 2019
Last Update
September 13 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.